首頁 > 市場調查報告書 > 製藥

婦科治療

市場調查報告書

商品編碼

1746637

日本荷爾蒙替代療法市場報告（按產品、給藥途徑、疾病類型和地區）2025-2033

Japan Hormone Replacement Therapy Market Report by Product, Route of Administration, Type of Disease, and Region 2025-2033

出版日期: 2025年06月02日 | 出版商:

IMARC | 英文 120 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2024年，日本荷爾蒙替代療法市場規模達5.678億美元。展望未來， IMARC Group預計到2033年，該市場規模將達到10.112億美元，2025-2033年期間的複合年成長率（CAGR）為6.60%。該行業正在經歷成長，主要得益於幾個關鍵促進因素，包括激素紊亂發病率的上升、顯著的技術進步、給藥技術的持續創新以及政府的支持性項目和報銷政策。

荷爾蒙替代療法 (HRT) 是一種用於治療個別荷爾蒙失衡的醫療方法。這種療法透過施用外源性荷爾蒙來補充或取代人體自身產生的荷爾蒙。通常，內分泌科醫生或婦科醫生等醫療保健提供者會在全面評估患者的病史和症狀後開立 HRT 處方。 HRT 的目標是透過持續控制荷爾蒙劑量來緩解與荷爾蒙缺乏或變化相關的症狀。治療過程中會進行嚴格的監測，以確保荷爾蒙水平保持在理想範圍內，從而促進整體健康，並可能減輕荷爾蒙失衡的負面影響。

日本荷爾蒙替代療法市場趨勢：

日本荷爾蒙替代療法市場正在經歷大幅成長，這得益於一系列與全球醫療保健趨勢相符的因素。其中一個關鍵促進因素是荷爾蒙失衡及相關疾病的盛行率不斷上升，而久坐不動的生活方式、壓力以及自然老化等因素導致這些疾病在人群中日益普遍。這些因素導致對荷爾蒙替代療法等治療干預措施的需求日益成長。此外，患者和醫護人員對HRT作為有效治療方案的認知和接受度不斷提高，也使市場受益匪淺。這種日益成長的認知促進了日本市場的擴張。日本人口老化是另一個重要促進因素，因為隨著年齡的成長，荷爾蒙失衡變得越來越普遍。這種人口結構的變化導致老年族群對HRT的需求增加。此外，透皮貼片和植入裝置等荷爾蒙給藥方法的持續技術進步，使得HRT的給藥更加便利、更有針對性。這提高了患者的依從性，改善了治療效果，進一步推動了市場成長。此外，旨在確保患者能夠負擔得起HRT治療的政府扶持措施和優惠的報銷政策，也為市場擴張創造了有利條件。這些因素將凸顯日本荷爾蒙替代療法市場在預測期內解決荷爾蒙失衡及相關健康問題方面日益成長的重要性和潛力。

日本荷爾蒙替代療法市場區隔：

產品洞察：

雌激素替代療法
人類生長激素替代療法
甲狀腺替代療法
睾酮替代療法
其他

給藥途徑洞察：

口服
腸外
透皮

疾病類型的見解：

停經
甲狀腺功能低下症
男性性腺功能低下
生長激素缺乏症
其他

競爭格局：

市場研究報告也對競爭格局進行了全面的分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀錶板和公司評估象限等競爭分析。此外，報告還提供了所有主要公司的詳細資料。

本報告回答的關鍵問題：

日本荷爾蒙替代療法市場迄今表現如何？未來幾年將如何表現？
COVID-19 對日本荷爾蒙替代療法市場有何影響？
日本荷爾蒙替代療法市場以產品分類是怎樣的？
根據給藥途徑，日本荷爾蒙替代療法市場是如何分類的？
日本荷爾蒙替代療法市場根據疾病類型如何分類？
日本荷爾蒙替代療法市場的價值鏈分為哪些階段？
日本荷爾蒙替代療法的主要促進因素和挑戰是什麼？
日本荷爾蒙替代療法市場的結構是怎麼樣的？主要參與者是誰？
日本荷爾蒙替代療法市場的競爭程度如何？

本報告回答的關鍵問題：

日本荷爾蒙替代療法市場迄今表現如何？未來幾年將如何表現？
COVID-19 對日本荷爾蒙替代療法市場有何影響？
日本荷爾蒙替代療法市場以產品分類是怎樣的？
根據給藥途徑，日本荷爾蒙替代療法市場是如何分類的？
日本荷爾蒙替代療法市場根據疾病類型如何分類？
日本荷爾蒙替代療法市場的價值鏈分為哪些階段？
日本荷爾蒙替代療法的主要促進因素和挑戰是什麼？
日本荷爾蒙替代療法市場的結構是怎麼樣的？主要參與者是誰？
日本荷爾蒙替代療法市場的競爭程度如何？

Japan hormone replacement therapy market size reached USD 567.8 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,011.2 Million by 2033, exhibiting a growth rate (CAGR) of 6.60% during 2025-2033. The industry is experiencing growth due to several key drivers, including the increasing incidence of hormonal disorders, notable technological advancements, continuous innovations in delivery techniques, and supportive government programs and reimbursement policies.

Hormone replacement therapy (HRT) is a medical approach employed to address hormonal imbalances in individuals. This treatment involves the administration of external hormones to supplement or substitute the natural hormones produced by the body. Typically, healthcare providers, such as endocrinologists or gynecologists, prescribe HRT after a comprehensive assessment of the patient's medical history and symptoms. HRT's objective is to alleviate symptoms related to hormonal deficiencies or variations by consistently delivering controlled hormone doses. The treatment undergoes careful monitoring to ensure that hormone levels remain within the desired range, promoting overall well-being and potentially mitigating the negative effects of hormonal imbalances.

Japan Hormone Replacement Therapy Market Trends:

The Japan hormone replacement therapy market is experiencing substantial growth, driven by a combination of factors that align with global healthcare trends. A key driver is the increasing prevalence of hormonal imbalances and related disorders, which are becoming more prevalent in the population due to factors like sedentary lifestyles, stress, and the natural process of aging. These factors have created a growing need for therapeutic interventions such as hormone replacement therapy. Furthermore, the market benefits from the rising awareness and acceptance of HRT as an effective treatment option among both patients and healthcare professionals. This increasing recognition has contributed to the expansion of the market in Japan. The aging demographic in Japan is another significant driver, as hormonal imbalances become more common with age. This demographic shift has led to a higher demand for HRT among the elderly population. Moreover, ongoing technological advancements in hormone delivery methods, such as transdermal patches and implantable devices, are making HRT more convenient and targeted in its administration. This enhances patient compliance and improves treatment outcomes, further fueling market growth. Additionally, supportive government initiatives and favorable reimbursement policies aimed at ensuring affordable access to HRT for patients are creating favorable conditions for market expansion. These collective factors will underscore the growing importance and potential of the Japan hormone replacement therapy market in addressing hormonal imbalances and related health concerns over the forecasted period.

Japan Hormone Replacement Therapy Market Segmentation:

Product Insights:

Estrogen Replacement Therapy
Human Growth Hormone Replacement Therapy
Thyroid Replacement Therapy
Testosterone Replacement Therapy
Others

Route of Administration Insights:

Oral
Parenteral
Transdermal

Type of Disease Insights:

Menopause
Hypothyroidism
Male Hypogonadism
Growth Hormone Deficiency
Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan hormone replacement therapy market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan hormone replacement therapy market?
What is the breakup of the Japan hormone replacement therapy market on the basis of product?
What is the breakup of the Japan hormone replacement therapy market on the basis of route of administration?
What is the breakup of the Japan hormone replacement therapy market on the basis of type of disease?
What are the various stages in the value chain of the Japan hormone replacement therapy market?
What are the key driving factors and challenges in the Japan hormone replacement therapy?
What is the structure of the Japan hormone replacement therapy market and who are the key players?
What is the degree of competition in the Japan hormone replacement therapy market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Hormone Replacement Therapy Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Hormone Replacement Therapy Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Hormone Replacement Therapy Market - Breakup by Product

6.1 Estrogen Replacement Therapy
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
6.2 Human Growth Hormone Replacement Therapy
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)
6.3 Thyroid Replacement Therapy
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2019-2024)
- 6.3.3 Market Forecast (2025-2033)
6.4 Testosterone Replacement Therapy
- 6.4.1 Overview
- 6.4.2 Historical and Current Market Trends (2019-2024)
- 6.4.3 Market Forecast (2025-2033)
6.5 Others
- 6.5.1 Historical and Current Market Trends (2019-2024)
- 6.5.2 Market Forecast (2025-2033)

7 Japan Hormone Replacement Therapy Market - Breakup by Route of Administration

7.1 Oral
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
7.2 Parenteral
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)
7.3 Transdermal
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2019-2024)
- 7.3.3 Market Forecast (2025-2033)

8 Japan Hormone Replacement Therapy Market - Breakup by Type of Disease

8.1 Menopause
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
8.2 Hypothyroidism
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
8.3 Male Hypogonadism
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)
8.4 Growth Hormone Deficiency
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2019-2024)
- 8.4.3 Market Forecast (2025-2033)
8.5 Others
- 8.5.1 Historical and Current Market Trends (2019-2024)
- 8.5.2 Market Forecast (2025-2033)

9 Japan Hormone Replacement Therapy Market - Competitive Landscape

9.1 Overview
9.2 Market Structure
9.3 Market Player Positioning
9.4 Top Winning Strategies
9.5 Competitive Dashboard
9.6 Company Evaluation Quadrant

10 Profiles of Key Players

10.1 Company A
- 10.1.1 Business Overview
- 10.1.2 Product Portfolio
- 10.1.3 Business Strategies
- 10.1.4 SWOT Analysis
- 10.1.5 Major News and Events
10.2 Company B
- 10.2.1 Business Overview
- 10.2.2 Product Portfolio
- 10.2.3 Business Strategies
- 10.2.4 SWOT Analysis
- 10.2.5 Major News and Events
10.3 Company C
- 10.3.1 Business Overview
- 10.3.2 Product Portfolio
- 10.3.3 Business Strategies
- 10.3.4 SWOT Analysis
- 10.3.5 Major News and Events
10.4 Company D
- 10.4.1 Business Overview
- 10.4.2 Product Portfolio
- 10.4.3 Business Strategies
- 10.4.4 SWOT Analysis
- 10.4.5 Major News and Events
10.5 Company E
- 10.5.1 Business Overview
- 10.5.2 Product Portfolio
- 10.5.3 Business Strategies
- 10.5.4 SWOT Analysis
- 10.5.5 Major News and Events

11 Japan Hormone Replacement Therapy Market - Industry Analysis

11.1 Drivers, Restraints, and Opportunities
- 11.1.1 Overview
- 11.1.2 Drivers
- 11.1.3 Restraints
- 11.1.4 Opportunities
11.2 Porters Five Forces Analysis
- 11.2.1 Overview
- 11.2.2 Bargaining Power of Buyers
- 11.2.3 Bargaining Power of Suppliers
- 11.2.4 Degree of Competition
- 11.2.5 Threat of New Entrants
- 11.2.6 Threat of Substitutes
11.3 Value Chain Analysis